Institute of Bioengineering and Nanotechnology, IBM reveal new antimicrobial hydrogel
Amid massive security, bird flu virus research awaits approval

FluGen studies show progress toward universal flu vaccine

By Kathleen Gallagher of the Journal Sentinel

FluGen Inc., a Madison vaccine and vaccine delivery product company, said it has done studies in animals suggesting a vaccine it has in development could be taken every three to five years and protect against a wide range of flu viruses - even those it was not designed to prevent.

Full story.

Please visit our sponsor Gehrke & Associates, SC to learn more about how to enhance and defend your intellectual property.  Thank you.

Comments